| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2009 | 2020 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1997 | 2020 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
cyclin dependent kinase 5 | 0.495 | 0.846 | 0.14 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.530 | None | 1.000 | 1 | 0 | 1993 | 2013 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.580 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1998 | 2020 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.510 | None | 1.000 | 1 | 0 | 2011 | 2018 | ||||||||
|
pro-apoptotic WT1 regulator | 0.542 | 0.846 | 9.0E-02 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2008 | 2011 | ||||||||
|
phosphodiesterase 4D | 0.519 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
solute carrier family 6 member 2 | 0.490 | 0.846 | 8.2E-02 |
|
disease | 0.600 | None | 0.800 | 1 | 0 | 2008 | 2020 | ||||||||
|
Fas associated via death domain | 0.537 | 0.846 | 0.53 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
mitofusin 2 | 0.471 | 0.846 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2010 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.600 | None | 0.800 | 1 | 0 | 1999 | 2020 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
disease | 0.580 | None | 1.000 | 1 | 0 | 2004 | 2020 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.270 | None | 1.000 | 1 | 0 | 2010 | 2018 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.210 | None | 0.500 | 1 | 0 | 2011 | 2019 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.500 | None | 0.800 | 1 | 0 | 2002 | 2014 |